CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2023 Earnings Call Transcript August 8, 2023
CytomX Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $0.19.
Operator: Good day, and welcome to the CytomX Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speaker’s presentation there will be a question and answer session. [Operator Instructions] Please be advised...
